| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |